January 2020
Nirmala Sharma, Arun Bhargav Jadhav, Anil Vishwanath Patil

 

Abstract

The World Health Organization (WHO) considers Hypertension (HTN) as a most common health issue in the growing population nowadays. Studies say that prevalence of essential hypertension is around 85- 95% and prevalence of secondary hypertension is only 5%.

However, homoeopathy is used as alternative in such cases i.e.; HTN, but it has very good clinical results in cases of HTN. Lachesis Muta 30C is the remedy for circulatory effect and has been observed in reduction of Blood Pressure (BP) by acting on circulation in many cases, but very few researches has been done to prove it.

This study was aimed to investigate whether the homoeopathic medicine Lachesis Muta 30C has effect in reducing blood pressure levels in essential hypertensive patients or not. It is a monocentric, phase II clinical trial, and single arm, single blind study conducted at outpatient department of Bharati Vidyapeeth Deemed University- Homoeopathic College & Research Centre, Pune.

Total 34 patients (Male and Female in between the age from 20 yrs to 75 yrs.) were enrolled in this study. Out of which, four patients were dropped out and 30 patients completed their follow-up. Blood pressure was measured in sitting position.

The final outcome was decrease in blood pressure after 10-12 weeks of outpatient care. A significant reduction observed in blood pressure levels of hypertensive patients before and after treatment and patients symptomatically relieved as well. The mean reduction in SBP was 8.80 mm of Hg (95% CI 9.9, 7.7) and DBP was 9.86mm of Hg (95% CI 10.2, 9.72) after Completion of study (10-12 weeks of treatment).

Homoeopathic medicine Lachesis Muta 30C produced significant effect in reduction of the blood pressure level on essential hypertensive patients.

Keywords: Lachesis Muta 30C, Hyperten-Sinogenic Factors, HTN, Silent Killer, Homoeopathy